Analgesic medicine sales in Sweden stood at 321.5 million USD PPP in 2023. The forecast data from 2024 to 2028 suggests a consistent year-on-year increase in sales value. Specifically, values are projected as follows: 2024 (328.8 million), 2025 (336.1 million), 2026 (343.4 million), 2027 (350.6 million), and 2028 (357.8 million). Year-on-year growth variations are expected to be around 2.2% for 2024-2025, and a similar rate is anticipated for the following years until 2028. The compound annual growth rate (CAGR) for the period 2023-2028 is approximately 2.1%.
Future trends to watch for include:
- Technological advancements in analgesic formulations
- Increased demand driven by aging population
- Regulatory changes and healthcare policies impacting drug prices
- Reimbursement policies and the influence of generic medications on market value
